Literature DB >> 10086856

Interleukin-15 is not a constitutive cytokine in the epidermis, but is inducible in culture or inflammatory conditions.

G W Han1, K Iwatsuki, M Inoue, T Matsui, A Nishibu, H Akiba, F Kaneko.   

Abstract

The regulation in the skin of interleukin-15 (IL-15), a potent modulator of T-cell-mediated immune responses, is not fully understood. We investigated the levels of IL-15 and its mRNA produced by epidermal and cultured keratinocytes and found that normal keratinocytes did not constitutively express IL-15 in the epidermis, but in culture began to produce the cytokine. Some epidermal keratinocytes expressed IL-15 in inflammatory conditions associated with infiltration of neutrophils and eosinophils. IL-15 was detected only in the cell lysates, not in the supernatants of cultured keratinocytes. Dexamethasone (10(-5)-10(-6) M) markedly inhibited IL-15 mRNA expression by normal and transformed keratinocytes in a range of pharmacological concentrations. IFN-gamma (200 and 400 U/ml) slightly increased the IL-15 message level in a squamous cell carcinoma cell line, HSC-5, in a dose-dependent fashion, whereas no significant change was observed in cultured normal human keratinocytes. Our data indicate that IL-15 is not a constitutive cytokine in epidermal keratinocytes but is inducible.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10086856     DOI: 10.1080/000155599750011679

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  6 in total

1.  IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin.

Authors:  Rachael A Clark; Thomas S Kupper
Journal:  Blood       Date:  2006-09-12       Impact factor: 22.113

2.  Low dose IL-15 induces snap arming of CD44(low) T lymphocytes in the absence of antigen.

Authors:  David L Tamang; Bryce N Alves; Viki Elliott; Stephanie A Fraser; Doug Redelman; Dorothy Hudig
Journal:  Cell Immunol       Date:  2008-05-16       Impact factor: 4.868

3.  Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.

Authors:  Anjali Mishra; Krista La Perle; Sonya Kwiatkowski; Laura A Sullivan; Gregory H Sams; Jessica Johns; Douglas P Curphey; Jing Wen; Kathleen McConnell; Jun Qi; Henry Wong; Giandomenico Russo; Jianying Zhang; Guido Marcucci; James E Bradner; Pierluigi Porcu; Michael A Caligiuri
Journal:  Cancer Discov       Date:  2016-07-15       Impact factor: 39.397

4.  Human keratinocytes' response to injury upregulates CCL20 and other genes linking innate and adaptive immunity.

Authors:  Milène Kennedy-Crispin; Erika Billick; Hiroshi Mitsui; Nicholas Gulati; Hideki Fujita; Patricia Gilleaudeau; Mary Sullivan-Whalen; Leanne M Johnson-Huang; Mayte Suárez-Fariñas; James G Krueger
Journal:  J Invest Dermatol       Date:  2011-09-01       Impact factor: 8.551

5.  S-calprotectin (S100A8/S100A9): a potential marker of inflammation in patients with psoriatic arthritis.

Authors:  Claes Hansson; Catharina Eriksson; Gerd-Marie Alenius
Journal:  J Immunol Res       Date:  2014-05-14       Impact factor: 4.818

6.  Accumulation of Cytotoxic Skin Resident Memory T Cells and Increased Expression of IL-15 in Lesional Skin of Polymorphic Light Eruption.

Authors:  VijayKumar Patra; Johanna Strobl; Denise Atzmüller; Bärbel Reininger; Lisa Kleissl; Alexandra Gruber-Wackernagel; Jean-Francois Nicolas; Georg Stary; Marc Vocanson; Peter Wolf
Journal:  Front Med (Lausanne)       Date:  2022-06-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.